Rudnick J R, Arduino M J, Bland L A, Cusick L, McAllister S K, Aguero S M, Jarvis W R
Investigation and Prevention Branch, U.S. Department of Health and Human Services, Atlanta, Georgia 30333, USA.
Artif Organs. 1995 Apr;19(4):289-94. doi: 10.1111/j.1525-1594.1995.tb02331.x.
In February 1992, 22 patients undergoing chronic hemodialysis at an outpatient dialysis center experienced pyrogenic reactions (PR). The PR rate was significantly greater (p < 0.001) during the epidemic (February 3-5) than the pre-epidemic period (November 1, 1992-February 1, 1992). All patients with PR used dialyzers that had been manually reprocessed either on February 1 or 3. These dialyzers contained up to 120.8 EU/ml of endotoxin in the blood compartment. The only dialyzer reprocessed before February 1 that was available for analysis was found to contain no detectable endotoxin, while dialyzers reprocessed during the epidemic period contained a median endotoxin concentration of 52.8 EU/ml. The bioburden of water used to prepare dialysate was in excess of the Association for the Advancement of Medical Instrumentation (AAMI) standard for water, < or = 200 colony forming units (CFU)/ml. Samples of treated water collected in the reuse area were within AAMI standards at the time of the investigation (February 11 and February 26), but before the investigation, water samples were assayed with a culture method that could not detect microbial concentrations below 10(3) CFU/ml. In addition, the treated water feed line to the disinfectant container may never have been disinfected. However, no samples were collected from this line during the investigation. This outbreak emphasizes the need to use water that meets the AAMI bacteriologic and endotoxin standards of < or = to 200 CFU/ml and/or 5 EU/ml, respectively, for reprocessing hemodialyzers nad to ensure that appropriate culture techniques are used for treated water dialysate.
1992年2月,一家门诊透析中心的22名接受慢性血液透析的患者发生了热原反应(PR)。疫情期间(2月3日至5日)的PR发生率显著高于疫情前时期(1992年11月1日至1992年2月1日)(p < 0.001)。所有发生PR的患者都使用了在2月1日或3日手动重新处理过的透析器。这些透析器的血液腔室中内毒素含量高达120.8 EU/ml。发现2月1日前唯一可用于分析的重新处理过的透析器未检测到内毒素,而疫情期间重新处理的透析器内毒素浓度中位数为52.8 EU/ml。用于制备透析液的水的生物负荷超过了美国医学仪器促进协会(AAMI)的水标准,即≤200菌落形成单位(CFU)/ml。在再利用区域采集的处理后水样本在调查时(2月11日和2月26日)符合AAMI标准,但在调查前,水样采用的培养方法无法检测到低于10³ CFU/ml的微生物浓度。此外,通往消毒容器的处理后水进料管线可能从未进行过消毒。然而,调查期间未从该管线采集样本。此次疫情强调了在重新处理血液透析器时需要使用分别符合AAMI细菌学和内毒素标准(即≤200 CFU/ml和/或5 EU/ml)的水,并确保对处理后水和透析液采用适当的培养技术。